Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Chronic graft-versus-host disease
2003697 citationsStephanie J. Lee, Georgia B. Vogelsang et al.Biology of Blood and Marrow Transplantationprofile →
VENOOCCLUSIVE DISEASE OF THE LIVER FOLLOWING BONE MARROW TRANSPLANTATION
1987673 citationsRichard J. Jones, William E. Beschorner et al.Transplantationprofile →
The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease
2016283 citationsKenneth R. Cooke, Leo Luznik et al.Biology of Blood and Marrow Transplantationprofile →
Measuring Therapeutic Response in Chronic Graft-versus-Host Disease. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2014 Response Criteria Working Group Report
2015280 citationsStephanie J. Lee, Madan Jagasia et al.Biology of Blood and Marrow Transplantationprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
Countries citing papers authored by Georgia B. Vogelsang
Since
Specialization
Citations
This map shows the geographic impact of Georgia B. Vogelsang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Georgia B. Vogelsang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Georgia B. Vogelsang more than expected).
Fields of papers citing papers by Georgia B. Vogelsang
This network shows the impact of papers produced by Georgia B. Vogelsang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Georgia B. Vogelsang. The network helps show where Georgia B. Vogelsang may publish in the future.
Co-authorship network of co-authors of Georgia B. Vogelsang
This figure shows the co-authorship network connecting the top 25 collaborators of Georgia B. Vogelsang.
A scholar is included among the top collaborators of Georgia B. Vogelsang based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Georgia B. Vogelsang. Georgia B. Vogelsang is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
20 of 20 papers shown
1.
Cooke, Kenneth R., Leo Luznik, Stefanie Sarantopoulos, et al.. (2016). The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation. 23(2). 211–234.283 indexed citations breakdown →
2.
Paczesny, Sophie, Frances T. Hakim, Joseph Pidala, et al.. (2015). National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-Versus-Host Disease: III. The 2014 Biomarker Working Group Report. PMC.1 indexed citations
3.
Bolaños‐Meade, Javier & Georgia B. Vogelsang. (2008). Chronic Graft-Versus-Host Disease. Current Pharmaceutical Design. 14(20). 1974–1986.10 indexed citations
4.
Jacobsohn, David A. & Georgia B. Vogelsang. (2007). Acute graft versus host disease. Orphanet Journal of Rare Diseases. 2(1). 35–35.187 indexed citations
Vogelsang, Georgia B. & Julie R. Brahmer. (2002). Patient-reported outcomes and managed care decisions: Quality of life and related components. The American Journal of Managed Care. 8.2 indexed citations
10.
Chaudhry, Vinay, David R. Cornblath, Andrea M. Corse, et al.. (2002). Thalidomide-induced neuropathy. Neurology. 59(12). 1872–1875.135 indexed citations
Aldershvile, Jan, et al.. (2000). [Circulatory support with the mechanical heart, "HeartMate"].. PubMed. 162(26). 3717–22.1 indexed citations
14.
Horn, Thomas, et al.. (1997). Lichen planus-like histopathologic characteristics in the cutaneous graft-vs-host reaction. Prognostic significance independent of time course after allogeneic bone marrow transplantation.. PubMed. 133(8). 961–5.28 indexed citations
Keenan, Robert J., G J Burckart, R. Scott Stuart, et al.. (1991). Immunosuppressive properties of thalidomide. Inhibition of in vitro lymphocyte proliferation alone and in combination with cyclosporine or FK506.. PubMed. 52(5). 908–10.38 indexed citations
Jones, Richard J., William E. Beschorner, Victor G. Vogel, et al.. (1987). VENOOCCLUSIVE DISEASE OF THE LIVER FOLLOWING BONE MARROW TRANSPLANTATION. Transplantation. 44(6). 778–783.673 indexed citations breakdown →
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.